$ONTO
ONTO INNOVATION INC. Stock $onto

$onto Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000070453215000038 Filed on October 30, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q4
Revenue	$42.70M	$45.68M	$39.70M
YoY Change	7.56%	68.35%	-14.07%
Cost Of Revenue	$21.90M	$23.46M	$22.40M
YoY Change	-2.23%	49.26%	-7.82%
Gross Profit	$20.80M	$22.22M	$17.30M
YoY Change	20.23%	94.63%	-21.0%
Gross Profit Margin	48.71%	48.64%	43.58%
Selling, General & Admin	$12.70M	$12.35M	$12.50M
YoY Change	1.6%	1.48%	0.0%
% of Gross Profit	61.06%	55.58%	72.25%
Research & Development	$7.800M	$8.579M	$8.100M
YoY Change	-3.7%	6.74%	1.25%
% of Gross Profit	37.5%	38.61%	46.82%
Depreciation & Amortization	$2.300M	$1.800M	$1.100M
YoY Change	109.09%	5.88%	-52.17%
% of Gross Profit	11.06%	8.1%	6.36%
Operating Expenses	$20.50M	$20.96M	$20.50M
YoY Change	0.0%	-4.86%	-0.49%
Operating Profit	$300.0K	$1.264M	-$3.200M
YoY Change	-109.38%	-111.91%	-346.15%
Interest Expense	$0.00	$86.00K	-$100.0K
YoY Change	-100.0%	-4.44%	0.0%
% of Operating Profit	0.0%	6.8%
Other Income/Expense, Net	$100.0K	$346.0K	$300.0K
YoY Change	-66.67%	-707.02%	-200.0%
Pretax Income	-$1.000M	$1.531M	-$3.600M
YoY Change	-72.22%	-114.25%	-500.0%
Income Tax	$800.0K	$713.0K	$1.000M
% Of Pretax Income		46.57%
Net Earnings	-$1.800M	$818.0K	-$4.600M
YoY Change	-60.87%	-102.85%	-866.67%
Net Earnings / Revenue	-4.22%	1.79%	-11.59%
Basic Earnings Per Share		$0.03
Diluted Earnings Per Share	-$74.38K	$0.03	-$191.7K
COMMON SHARES
Basic Shares Outstanding	24.19M shares	24.15M shares	24.16M shares
Diluted Shares Outstanding		24.35M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$83.10M	$84.60M	$84.00M
YoY Change	-1.07%	0.24%	-9.58%
Cash & Equivalents	$38.15M	$41.56M	$34.68M
Short-Term Investments	$44.90M	$43.10M	$49.30M
Other Short-Term Assets	$6.600M	$8.100M	$10.80M
YoY Change	-38.89%	-34.15%	-56.8%
Inventory	$47.75M	$48.40M	$35.11M
Prepaid Expenses
Receivables	$37.83M	$37.57M	$26.12M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$178.1M	$180.2M	$157.8M
YoY Change	12.84%	13.37%	-17.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$44.49M	$45.94M	$49.63M
YoY Change	-10.36%	-9.44%	4.62%
Goodwill	$9.415M	$9.678M	$10.49M
YoY Change	-10.28%	-12.33%	-10.64%
Intangibles		$2.403M	$4.294M
YoY Change		-54.27%	-45.4%
Long-Term Investments
YoY Change
Other Assets	$533.0K	$497.0K	$559.0K
YoY Change	-4.65%	-16.19%	-19.68%
Total Long-Term Assets	$57.43M	$58.91M	$65.39M
YoY Change	-12.18%	-13.35%	-9.28%
TOTAL ASSETS
Total Short-Term Assets	$178.1M	$180.2M	$157.8M
Total Long-Term Assets	$57.43M	$58.91M	$65.39M
Total Assets	$235.5M	$239.1M	$223.2M
YoY Change	5.51%	5.36%	-15.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.68M	$15.88M	$10.20M
YoY Change	14.47%	167.01%	-3.82%
Accrued Expenses	$15.30M	$15.30M	$13.40M
YoY Change	14.18%	26.45%	13.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.21M	$47.55M	$38.20M
YoY Change	18.35%	65.33%	-21.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$878.0K	$1.018M	$1.279M
YoY Change	-31.35%	-39.15%	-20.8%
Total Long-Term Liabilities	$878.0K	$1.018M	$1.279M
YoY Change	-31.35%	-39.15%	-20.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.21M	$47.55M	$38.20M
Total Long-Term Liabilities	$878.0K	$1.018M	$1.279M
Total Liabilities	$48.21M	$51.34M	$43.70M
YoY Change	10.33%	38.67%	-21.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$66.21M	-$64.40M	-$69.11M
YoY Change	-4.2%	-0.12%	81.9%
Common Stock	$258.7M	$24.00K	$24.00K
YoY Change	1077979.17%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$187.3M	$187.8M	$179.5M
YoY Change
Total Liabilities & Shareholders Equity	$235.5M	$239.1M	$223.2M
YoY Change	5.51%	5.36%	-15.07%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	-$1.800M	$818.0K	-$4.600M
YoY Change	-60.87%	-102.85%	-866.67%
Depreciation, Depletion And Amortization	$2.300M	$1.800M	$1.100M
YoY Change	109.09%	5.88%	-52.17%
Cash From Operating Activities	-$700.0K	$9.500M	$8.900M
YoY Change	-107.87%	-293.88%	493.33%
INVESTING ACTIVITIES
Capital Expenditures	-$400.0K	-$400.0K	-$3.000M
YoY Change	-86.67%	-140.0%	36.36%
Acquisitions
YoY Change
Other Investing Activities	-$2.100M	$5.200M	-$1.100M
YoY Change	90.91%	642.86%	-257.14%
Cash From Investing Activities	-$2.500M	$4.900M	-$4.100M
YoY Change	-39.02%	188.24%	173.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	900.0K	-5.400M
YoY Change	-100.0%	-35.71%	-775.0%
NET CHANGE
Cash From Operating Activities	-700.0K	9.500M	8.900M
Cash From Investing Activities	-2.500M	4.900M	-4.100M
Cash From Financing Activities	0.000	900.0K	-5.400M
Net Change In Cash	-3.200M	15.30M	-600.0K
YoY Change	433.33%	-950.0%	-175.0%
FREE CASH FLOW
Cash From Operating Activities	-$700.0K	$9.500M	$8.900M
Capital Expenditures	-$400.0K	-$400.0K	-$3.000M
Free Cash Flow	-$300.0K	$9.900M	$11.90M
YoY Change	-102.52%	-267.8%	221.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-26
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-26
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000704532
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24188234	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NANOMETRICS INC
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
	nano	Amortization Expense Finite Lived Intangible Assets AmortizationExpenseFiniteLivedIntangibleAssets	2300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24896000	USD
CY2014Q3	us-gaap	Restructuring Charges RestructuringCharges	1715000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1715000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	2300000	USD
	nano	Increase Decrease Inventories Delivered Systems IncreaseDecreaseInventoriesDeliveredSystems	-6400000	USD
	nano	Increase Decrease Inventories Delivered Systems IncreaseDecreaseInventoriesDeliveredSystems	-370000	USD
CY2014Q4	nano	Intellectual Property Indemnification Obligations IntellectualPropertyIndemnificationObligations	0	USD
CY2015Q3	nano	Intellectual Property Indemnification Obligations IntellectualPropertyIndemnificationObligations	0	USD
	nano	Amortization Expense Finite Lived Intangible Assets AmortizationExpenseFiniteLivedIntangibleAssets	1600000	USD
	nano	Changes In Fair Value Of Contingent Payments ChangesInFairValueOfContingentPayments	118000	USD
	nano	Changes In Fair Value Of Contingent Payments ChangesInFairValueOfContingentPayments	137000	USD
CY2014Q3	nano	Cost Of Products Amortization Of Intangible Assets CostOfProductsAmortizationOfIntangibleAssets	688000	USD
	nano	Cost Of Products Amortization Of Intangible Assets CostOfProductsAmortizationOfIntangibleAssets	2039000	USD
CY2015Q3	nano	Due From Unrelated Third Parties DueFromUnrelatedThirdParties	0	USD
CY2015Q3	nano	Finite Lived Intangible Assets Amortization Expense Estimated Future Amount FiniteLivedIntangibleAssetsAmortizationExpenseEstimatedFutureAmount	2403000	USD
CY2014Q4	nano	Inventories Delivered Systems InventoriesDeliveredSystems	1912000	USD
CY2015Q3	nano	Cost Of Products Amortization Of Intangible Assets CostOfProductsAmortizationOfIntangibleAssets	468000	USD
	nano	Cost Of Products Amortization Of Intangible Assets CostOfProductsAmortizationOfIntangibleAssets	1557000	USD
CY2014Q4	nano	Due From Unrelated Third Parties DueFromUnrelatedThirdParties	0	USD
CY2015Q3	nano	Inventories Delivered Systems InventoriesDeliveredSystems	1543000	USD
CY2014Q4	nano	Inventory Inventory	37017000	USD
CY2015Q3	nano	Inventory Inventory	49941000	USD
CY2014	nano	Investment Maturity Period Maximum InvestmentMaturityPeriodMaximum	P2Y
	nano	Investment Maturity Period Maximum InvestmentMaturityPeriodMaximum	P2Y
CY2014Q2	nano	Line Of Credit Facility Borrowing Limit Under Condition Two LineOfCreditFacilityBorrowingLimitUnderConditionTwo	20000000	USD
CY2014Q2	nano	Line Of Credit Facility Date Of Maturity LineOfCreditFacilityDateOfMaturity	2016-05-30
CY2014Q2	nano	Line Of Credit Facility Standard Borrowing Limit Under Condition One LineOfCreditFacilityStandardBorrowingLimitUnderConditionOne	12000000	USD
	nano	Maximum Period Of Delivery To Customers MaximumPeriodOfDeliveryToCustomers	P6M
	nano	Maximum Period Services Provided Over Fixed Arrangement Term MaximumPeriodServicesProvidedOverFixedArrangementTerm	P12M
CY2014Q3	nano	Other Income Expense Net OtherIncomeExpenseNet	-134000	USD
	nano	Other Income Expense Net OtherIncomeExpenseNet	-138000	USD
CY2015Q3	nano	Other Income Expense Net OtherIncomeExpenseNet	267000	USD
	nano	Other Income Expense Net OtherIncomeExpenseNet	551000	USD
CY2014Q3	nano	Proceeds From Accounts Receivable ProceedsFromAccountsReceivable	1300000	USD
	nano	Proceeds From Accounts Receivable ProceedsFromAccountsReceivable	2900000	USD
CY2015Q3	nano	Proceeds From Accounts Receivable ProceedsFromAccountsReceivable	2400000	USD
	nano	Proceeds From Accounts Receivable ProceedsFromAccountsReceivable	5400000	USD
	nano	Product Warranty Period ProductWarrantyPeriod	P12M
CY2015Q3	nano	Share Based Compensation Arrangements By Share Based Payment Award Options Share Closing Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsShareClosingPrice	12.33
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10199000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	15882000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26121000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37573000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1017000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1236000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	778000	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	671000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28715000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34276000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2769000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4707000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	251396000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	256878000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1705000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5115000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1682000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4664000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	253000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	159000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	103000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	318000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	89000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	400000	shares
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2014Q4	us-gaap	Assets Assets	223236000	USD
CY2015Q3	us-gaap	Assets Assets	239136000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	157846000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	180229000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	83962000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	84626000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	25000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	53000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	8000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	84012000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	173000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10021000	USD
CY2014Q3	us-gaap	Cost Of Services CostOfServices	4292000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10985000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2591000	USD
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	84609000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1385000	USD
CY2015Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1159000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44765000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35625000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34676000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41561000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9140000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6885000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23813729	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24176806	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23813729	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24176806	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	24000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	24000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30314000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27738000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2780000	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15717000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68265000	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23459000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	75821000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	10737000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	52165000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	19242000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	59106000	USD
	us-gaap	Cost Of Services CostOfServices	14061000	USD
CY2015Q3	us-gaap	Cost Of Services CostOfServices	3749000	USD
	us-gaap	Cost Of Services CostOfServices	15158000	USD
CY2014Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.030
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	20776000	USD
CY2015Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	939000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1457000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1438000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	410000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	385000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	926000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1054000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	1700000	USD
	us-gaap	Depreciation Depreciation	4900000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	1800000	USD
	us-gaap	Depreciation Depreciation	5200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8660000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6826000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.11
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.11
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-269000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-166000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8700000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10025000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26376000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27543000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	473000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	66000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	140000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	206000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1518000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	30670000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29946000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4294000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2403000	USD
	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P91D
	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P91D
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-80000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-578000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5781000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18120000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5590000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16901000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	10494000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	9678000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-816000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	11416000	USD
	us-gaap	Gross Profit GrossProfit	58473000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	22219000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7985000	USD
	us-gaap	Gross Profit GrossProfit	68861000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10743000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	37000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	63000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	35105000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	48398000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19463000	USD
CY2015Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	24999000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7723000	USD
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14463000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1109000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1971000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1531000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6565000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17919000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18494000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	713000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1847000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4535000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9634000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4871000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14873000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3158000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	295000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-16270000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-688000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7998000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15893000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1751000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4436000	USD
CY2015Q3	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	400000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4294000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2403000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	90000	USD
	us-gaap	Interest Expense InterestExpense	286000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	86000	USD
	us-gaap	Interest Expense InterestExpense	252000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7919000	USD
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8936000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	43699000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	51337000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	223236000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	239136000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38202000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	47550000	USD
CY2015Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	17900000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	203000	USD
CY2014Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	12000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4718000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4040000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4500000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9549000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2348000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-28662000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26479000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	818000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4718000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	49633000	USD
CY2015Q3	us-gaap	Noncurrent Assets NoncurrentAssets	45944000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	22025000	USD
	us-gaap	Operating Expenses OperatingExpenses	66320000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	20955000	USD
	us-gaap	Operating Expenses OperatingExpenses	62847000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10609000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7847000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1264000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	6014000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2152000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2960000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	559000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	497000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-15000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-7000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	17000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	42000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1637000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1252000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-235000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1980000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1938000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1652000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1259000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-218000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1938000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8265000	USD
CY2015Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9422000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1279000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1018000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-57000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	111000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	346000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	740000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1721000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	432000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	712000	USD
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	470000	USD
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	614000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	664000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1104000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	26810000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	27298000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2800000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1365000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9289000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6651000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5852000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3642000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	25570000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	30279000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2884000	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3426000	USD
CY2014Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3484000	USD
CY2014Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2990000	USD
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2953000	USD
CY2015Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3792000	USD
CY2015Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4291000	USD
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2953000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4291000	USD
CY2014Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1736000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	4895000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1789000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	4902000	USD
CY2014Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1242000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4459000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	2288000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	6240000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	78348000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80220000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49633000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45944000	USD
	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	4627000	USD
	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	1068000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8037000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25724000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64396000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8579000	USD
CY2014Q3	us-gaap	Restructuring Reserve RestructuringReserve	1283000	USD
CY2015Q3	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	56000	USD
CY2013Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2014Q4	us-gaap	Restructuring Reserve RestructuringReserve	997000	USD
CY2015Q3	us-gaap	Restructuring Reserve RestructuringReserve	341000	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	997000	USD
CY2015Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	341000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69114000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	19487000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	101991000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	36414000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	113689000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	27133000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	126738000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	45678000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	144682000	USD
CY2014Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	7646000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	24747000	USD
CY2015Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	9264000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	30993000	USD
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6389000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20443000	USD
CY2015Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6760000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20905000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5115000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4664000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	948053	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.07
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2900000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1400000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	72527	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.13
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4108000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	925000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1382993	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1119429	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.92
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.40
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.86
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.22
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	925000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y3M11D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M28D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M17D
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	49286000	USD
CY2015Q3	us-gaap	Short Term Investments ShortTermInvestments	43065000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	191037	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	179537000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	187799000	USD
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	701000	USD
CY2015Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	776000	USD
CY2014Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	21100000	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	21100000	USD
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	207000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	337000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24132000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23928000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24352000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24347000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24132000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23928000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24145000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24010000	shares
	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives - </font><font style="font-family:inherit;font-size:10pt;">The Company enters into forward foreign currency contracts that economically hedge the gains and losses generated by the re-measurement of certain recorded assets and liabilities in a non-functional currency and to offset certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions. Changes in the fair value of these undesignated hedges are recognized in other income (expense), net immediately as an offset to the changes in the fair value of the asset or liability being hedged.</font></div></div>
	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal Period</font><font style="font-family:inherit;font-size:10pt;"> – The Company uses a 52/53 week fiscal year ending on the last Saturday of the calendar year. All references to the quarter refer to Nanometrics’ fiscal quarter. The fiscal quarters presented herein consist of 13 weeks. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates </font><font style="font-family:inherit;font-size:10pt;">– The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates. Estimates are used for, but not limited to, revenue recognition, the provision for doubtful accounts, the provision for excess, obsolete, or slow moving inventories, valuation of intangible and long-lived assets, warranty accruals, income taxes, valuation of stock-based compensation, and contingencies.</font></div></div>

Files In Submission

Name	View Source	Status
0000704532-15-000038-index-headers.html	Edgar Link	pending
0000704532-15-000038-index.html	Edgar Link	pending
0000704532-15-000038.txt	Edgar Link	pending
0000704532-15-000038-xbrl.zip	Edgar Link	pending
bodcompex102.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nano-20150926.xml	Edgar Link	completed
nano-20150926.xsd	Edgar Link	pending
nano-20150926_cal.xml	Edgar Link	unprocessable
nano-20150926_def.xml	Edgar Link	unprocessable
nano-20150926_lab.xml	Edgar Link	unprocessable
nano-20150926_pre.xml	Edgar Link	unprocessable
q320159261510-q.htm	Edgar Link	pending
q3201592615exhibit311.htm	Edgar Link	pending
q3201592615exhibit312.htm	Edgar Link	pending
q3201592615exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tayloragreementex101.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONTO
ONTO INNOVATION INC. Stock $onto

2015 Q4 Form 10-Q Financial Statement

#000070453215000038 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONTO ONTO INNOVATION INC. Stock $onto

2015 Q4 Form 10-Q Financial Statement

#000070453215000038 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONTO
ONTO INNOVATION INC. Stock $onto